Centene to pay $13.7 million in New Mexico prescription drug price transparency suit

Managed care company Centene has agreed to pay $13.7 million to New Mexico to settle an investigation into its subsidiaries' inflationary pricing and reporting of pharmacy benefits in the state's Medicaid program, which is overseen by the state's Human Services Department.  

Read the full post at News Feed
Vote This Post DownVote This Post Up (No Ratings Yet)
Explore the Archive